Back to Report Store Home

Global Cancer Vaccines Market to 2022 – Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19

  • Published: Nov-2016
  • Report Code: GBIHC424MR
  • Report Format: pdf

Description

List of Tables

Table 1: Cancer Vaccines Market, Global, Symptoms of Key Indication Cancers, 2016 12

Table 2: Cancer Vaccines Market, Global, Infectious Agents and Associated Cancers, 2016 14

Table 3: Cancer Vaccines Market, Global, Epidemiology of Key Oncology Indications, 2016 16

Table 4: Cancer Vaccines Market, Complications Associated with Cervical, Liver, Melanoma and Prostate Cancers, 2016 21

Table 5: Cancer Vaccines Market, Optimal Chemotherapy Usage Rates 25

Table 6: Cancer Vaccines Market, Global, Approved Indications for Gardasil, 2016 32

Table 7: Cancer Vaccines Market, Global, Approved Indications for Provenge, 2016 34

Table 8: Cancer Vaccines Market, Global, Approved Indications for Cervarix, 2016 35

Table 9: Cancer Vaccines Market, Global, Approved Indications for Imlygic, 2016 37

Table 10: Cancer Vaccines Market, Global, Approved Indications for DCVax-L, 2016 38

Table 11: Cancer Vaccines Market, Global, Approved Indications for Recombivax HB, 2016 39

Table 13: Cancer Vaccines Market, Global, Usage of Prophylactic and Therapeutic Vaccines Across Key Indications, 2016 77

Table 14: Cancer Vaccines Market, Global, Forecast Revenue by Company, 2015–2022 86

Table 15: Cancer Vaccines Market, Global, Disclosed Licensing Deals, 2006–2016 105

Table 15: Cancer Vaccines Market, Global, Disclosed Co-development Deals, 2006–2016 113

Table 16: Cancer Vaccines, Global, All Pipeline Products, 2016 127

Table 17: Abbreviations 182

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$4995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$9990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$14985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards